Vanguard Group Inc Benitec Biopharma Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.31 - $6.32 $1,115 - $22,739
-3,598 Reduced 4.59%
74,773 $28,000
Q3 2021

Nov 12, 2021
BUY
$3.49 - $4.26 $12,557 - $15,327
3,598 Added 4.81%
78,371 $280,000
Q2 2021

Aug 13, 2021
BUY
$3.94 - $5.81 $294,605 - $434,431
74,773 New
74,773 $318,000

Others Institutions Holding BNTC

# of Institutions
3
Shares Held
1.42M
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $280M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email